The main research objectives of CAPSTONE is to deliver disruptive therapeutic innovation in two areas – autoimmune diseases and cancer – based on scientific excellence with high interdisciplinary and intersectoral permeability.
The research will be articulated into 3 workpackages:
By targeting events upstream of immune response, CAPSTONE wishes to provide a way to
to boost cancer immunotherapy and tame autoimmune conditions which there is a high therapeutic need.
